<DOC>
	<DOC>NCT01091935</DOC>
	<brief_summary>The purpose of this study is to prospectively determine the side effects profile in adults with neuropathic pain receiving intravenous infusions of lidocaine 5 mg per kg of lean body weight, infused over 45 minutes.</brief_summary>
	<brief_title>Safety of Intravenous Lidocaine Infusions</brief_title>
	<detailed_description>Eligibility Criteria: Adults &gt; 18 yrs with chronic central or peripheral neuropathic pain at the St Joseph's Health Care Pain Clinic between June and December 2009. Outcome measures: All side effects spontaneously reported. Sedation, nausea, dizziness by Visual Analog Score Q 15 minutes; hemodynamic data q 5 minutes during and after infusion for 30 minutes. Daily diary of side effects and Visual Analogue score of Pain for 7 days post-infusion.</detailed_description>
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Lidocaine</mesh_term>
	<criteria>Adult outpatients &gt; 18 years &lt; 80 years diagnosed with chronic neuropathic pain Unable to provide informed consent Unable to speak and understand English Liver, kidney, or cardiac failure Allergy to Lidocaine</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2010</verification_date>
	<keyword>Lidocaine,Intravenous Infusions,Neuropathic Pain,Side Effects</keyword>
</DOC>